Seagen pushes ahead with growth plans after deal to be acquired by Pfizer

The Bothell-based biotech, which is building a 270,000-square-foot biomanufacturing plant, will keep its local facilities as Pfizer finalizes the $43 billion purchase.
Click here to view original post